绝经后骨质疏松症女性的周期性阿仑膦酸盐治疗。 - Suppr | 超能文献

Cyclical alendronate treatment in postmenopausal women with osteoporosis.

作者信息

Köşüş A, Capar M, Köşüş N

机构信息

Department of Obstetrics and Gynecology, Selcuk University, Meram Faculty of Medicine, Konya, Turkey.

出版信息

Int J Gynaecol Obstet. 2005 Nov;91(2):182-4. doi: 10.1016/j.ijgo.2005.06.026. Epub 2005 Aug 11.

DOI:10.1016/j.ijgo.2005.06.026

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Cyclical alendronate treatment in postmenopausal women with osteoporosis.绝经后骨质疏松症女性的周期性阿仑膦酸盐治疗。

Int J Gynaecol Obstet. 2005 Nov;91(2):182-4. doi: 10.1016/j.ijgo.2005.06.026. Epub 2005 Aug 11.

2

Comparison of the effects of alendronate and risedronate on bone mineral density and bone turnover markers in postmenopausal osteoporosis.阿仑膦酸盐和利塞膦酸盐对绝经后骨质疏松症患者骨密度及骨转换标志物影响的比较

Rheumatol Int. 2006 Jan;26(3):195-200. doi: 10.1007/s00296-004-0544-z. Epub 2004 Dec 2.

3

Alendronate increases spine and hip bone mineral density in women with postmenopausal osteoporosis who failed to respond to intermittent cyclical etidronate.阿仑膦酸钠可增加对间歇性周期性依替膦酸治疗无反应的绝经后骨质疏松症女性的脊柱和髋部骨矿物质密度。

Bone. 1999 Jan;24(1):65-8. doi: 10.1016/s8756-3282(98)00144-6.

4

Changes in bone markers after once-weekly low-dose alendronate in postmenopausal women with moderate bone loss.每周一次低剂量阿仑膦酸钠治疗中度骨质流失绝经后女性后骨标志物的变化

Maturitas. 2008 Jun 20;60(2):170-6. doi: 10.1016/j.maturitas.2008.05.003. Epub 2008 Jun 24.

5

Cost-minimization study comparing annual infusion of zoledronic acid or weekly oral alendronate in women with low bone mineral density.一项成本最小化研究，比较唑来膦酸年度输注与阿仑膦酸钠每周口服给药对低骨密度女性的治疗效果。

J Clin Densitom. 2014 Oct-Dec;17(4):484-9. doi: 10.1016/j.jocd.2013.12.001. Epub 2014 Mar 5.

6

Short-term variations in bone remodeling biochemical markers: cyclical etidronate and alendronate effects compared.骨重塑生化标志物的短期变化：环磷腺苷效应元件结合蛋白与阿仑膦酸盐作用的比较

J Clin Endocrinol Metab. 1997 Sep;82(9):3034-9. doi: 10.1210/jcem.82.9.4193.

7

[FACT study].[事实研究]

Nihon Rinsho. 2007 Nov 28;65 Suppl 9:280-5.

8

A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis: 24-month results from FACTS-International.阿仑膦酸盐与利塞膦酸盐对绝经后骨质疏松症女性骨矿物质密度影响的比较：FACTS-国际研究的24个月结果

Int J Clin Pract. 2008 Apr;62(4):575-84. doi: 10.1111/j.1742-1241.2008.01704.x.

9

[Weekly Fosamax tablet is significantly more effective than risedronate daily, as results of the Head-to-Head Study show].[头对头研究结果显示，每周一次的福善美片剂比每日一次的利塞膦酸盐显著更有效]

Praxis (Bern 1994). 2004 Sep 1;93(36):1454.

10

[An advantage for compliance: alendronate once weekly].[依从性方面的一个优势：阿仑膦酸钠每周一次]

MMW Fortschr Med. 2005 Dec 8;147(49-50):75.

引用本文的文献

1

Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.阿仑膦酸钠用于绝经后妇女骨质疏松性骨折的一级和二级预防。

Cochrane Database Syst Rev. 2025 Jan 27;1(1):CD001155. doi: 10.1002/14651858.CD001155.pub3.

2

Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.依替膦酸二钠用于绝经后妇女骨质疏松性骨折的一级和二级预防。

Cochrane Database Syst Rev. 2024 Apr 9;4(4):CD003376. doi: 10.1002/14651858.CD003376.pub4.